News

Special Sections

AgeX Therapeutics Reports Publication of Data Supporting Type II Diabetes and Obesity Therapy

Edward Kim | Equities.com |

Data in peer-reviewed journal support AgeX's stem cell therapeutic approach to metabolic diseases.


Dyadic International — Microcap Play in Multibillion-Dollar Biosimilars Market

Edward Kim | Equities.com |

Presenting at Biotech Showcase, Wednesday, Jan. 9, at 9am PT


Axsome Shows Positive Phase 2 Data in Major Depressive Disorder

Edward Kim | Equities.com |

AXS-05's novel multimodal mechanism of action is different from all currently marketed antidepressants (Image: Axsome).


NeuBase Therapeutics to Reverse Merge into Ohr Pharmaceutical

Edward Kim | Equities.com |

NeuBase will capture Ohr's Nasdaq listing as it develops therapies for genetic diseases caused by mutant proteins.


Bristol-Myers Squibb to Buy Celgene for $74 Billion

Edward Kim | Equities.com |

CELG shareholders to receive one BMY share + $50 in cash + 1 contingent value right worth potentially $9 for each CELG share


Exicure Shows Positive Early Data in Topical Psoriasis Treatment

Edward Kim | Equities.com |

First demonstrated clinical benefit of company's proprietary spherical nucleic acid (SNA) platform (Image: Exicure)


Biotech IPOs Raise Record Amount of $8.65 Billion in 2018

Edward Kim | Equities.com |

80 deals created $44.8 billion of market value for newly public US biotechs (Image: Genomics Law Report).


Harpoon Therapeutics Files for $75 Million IPO for Cancer Immunotherapy

Edward Kim | Equities.com |

Developing T cell engagers targeting prostate cancer, ovarian cancer, multiple myeloma and small cell lung cancer (Image: Harpoon Therapeutics)


Opiant Pharmaceuticals Licenses Cannabinoid Overdose Therapy from Sanofi

Edward Kim | Equities.com |

Opiant is the developer of Narcan for opioid overdoses


Measuring the Level of Competition for Valuable Minerals

Visual Capitalist | Equities.com |

Which resource markets have healthy levels of competition, and which are more monopolistic? This chart shows the global level of competition for 33 minerals.


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Dr. Martin Eaton - Heads Up Checkup

Equities.com Host & Contributor Silvia Davi interviewing CEO of Heads Up Checkup, Dr. Martin Eaton.